Sana Biotechnology, Inc.
SANA
$3.20
-$0.06-1.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 4.41% | -19.88% | 29.66% | -86.51% | 54.05% |
| Total Depreciation and Amortization | -34.48% | -19.70% | -21.35% | -26.65% | -2.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 75.65% | 419.82% | 101.16% | 522.31% | -82.57% |
| Change in Net Operating Assets | 40.06% | -20.07% | 302.62% | -243.34% | -45.53% |
| Cash from Operations | 23.18% | 30.79% | 43.21% | 43.46% | 25.86% |
| Capital Expenditure | -111.76% | -100.23% | 99.00% | 100.86% | 99.14% |
| Sale of Property, Plant, and Equipment | -1.98% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 200.12% | -134.26% | -204.91% | -61.93% | 126.86% |
| Cash from Investing | 197.76% | -135.03% | -214.96% | 32.00% | 121.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.06% | -- | -- | -- | -- |
| Issuance of Common Stock | -94.76% | 2,437.77% | 5,639.63% | -80.43% | -99.40% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -60.00% | -- | -- | -- | -- |
| Cash from Financing | -113.03% | 2,644.95% | 5,161.29% | -94.72% | -99.47% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 138.39% | -5,624.04% | 502.99% | 40.94% | -171.37% |